Clinical trials and medical research - What we don't know 

How research answers what we don't know 

There are many questions about health, illness and the effects of treatment for which there are no clear answers. Knowing what the questions are makes it easier to say what future research studies should look at.

For example, there is no medical consensus about the best treatment for an enlarged prostate gland in men (also known as benign prostatic hyperplasia or BPH). The enlargement causes urinary problems, such as increasing the number of times a man has to urinate, having to urinate urgently and reducing the flow of urine.

BPH can be treated with lifestyle changes, medicines or surgery, or by simply keeping an eye on things (known as watchful waiting). There is no convincing evidence that one type of treatment is better than the other, and it may be a matter of personal choice by the doctor or patient, depending on what symptoms the condition causes.

Research is important to try to understand which treatment may work best and when.

The right research project

There is benefit in repeating research if uncertainties remain. However, if the answer is already known, it will be more important to move on and ask another research question.

Doctors, researchers and increasingly patients and the public review the research that has been carried out and try to choose research projects that look at important unanswered questions.

Research ethics committees now ask researchers and others seeking approval for new trials to show that they have already reviewed previous research systematically (systematic reviews). If they do this, researchers are more likely to choose an appropriate research project and get an answer that will be helpful to patients.

Collecting together what is unknown

Researchers and scientists have, for centuries, made huge efforts to collect together what they know in medical libraries and, more recently, in electronic databases. Now, researchers are collecting what they are not sure about in the UK Database of Uncertainties about the Effects of Treatments (UK DUETs).

The main aim of DUETs is to help people decide which of the unanswered questions are most important, such as how prostate cancer should be managed.

DUETs identifies the need for future research using guidelines from the National Institute for Health and Clinical Excellence (NICE) and other publications that highlight gaps in knowledge.

Researchers also have increasing interest in the questions that matter to people who are ill, their families and those who care for them. The James Lind Alliance helps patients and medical professionals decide which uncertainties should be prioritised for further research.

Last reviewed: 14/01/2013

Next review due: 14/01/2015

Ratings

How helpful is this page?

Average rating

Based on 7 ratings

All ratings

Add your rating

Managing prostate cancer

There are uncertainties about whether it is a good idea to diagnose prostate cancer early. This is because the disease is often so slow moving that it does not become a life threatening condition.

There are also uncertainties about how best to investigate possible cases of prostate cancer and how to treat them. Only good research can address and reduce these uncertainties.

Read more about prostate cancer screening.